Similar articles

• BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

  Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, Quandt J, Bidmon N, Ulges A, Baum A, Pascal KE, Maurus D, Brachtendorf S, Lörks V, Sikorski J, Koch P, Hilker R, Becker D, Eller AK, Grützner J, Tonigold M, Boesler C, Rosenbaum C, Heesen L, Kühnle MC, Poran A, Dong JZ, Luxemburger U, Kemmer-Brück A, Langer D, Bexon M, Bolte S, Palanche T, Schultz A, Baumann S, Mahiny AJ, Boros G, Reinholz J, Szabó GT, Karikó K, Shi PY, Fontes-Garfias C, Perez JL, Cutler M, Cooper D, Kyratsous CA, Dormitzer PR, Jansen KU, Türeci Ö. Sahin U, et al. Nature. 2021 Jul;595(7868):572-577. doi: 10.1038/s41586-021-03653-6. Epub 2021 May 27. Nature. 2021. PMID: 34044428 Clinical Trial.
• Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies.

  Noori M, Nejadghaderi SA, Arshi S, Carson-Chahhoud K, Ansarin K, Kolahi AA, Safiri S. Noori M, et al. Rev Med Virol. 2022 Mar;32(2):e2277. doi: 10.1002/rmv.2277. Epub 2021 Jul 19. Rev Med Virol. 2022. PMID: 34286893 Free PMC article.
• A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting.

  Mat Yassim AS, Mohd Hisham AA, Nik Daud NNA, Anuar ND, Tan TM, Suppian R, Siti Asmaa MJ, Mohamad Asri AA, Azlan M, Idris NS, Muhamad R, Norazmi MN. Mat Yassim AS, et al. Sci Rep. 2025 Jul 1;15(1):21175. doi: 10.1038/s41598-025-05377-3. Sci Rep. 2025. PMID: 40594462 Free PMC article.
• Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases.

  Hadjadj J, Planas D, Ouedrani A, Buffier S, Delage L, Nguyen Y, Bruel T, Stolzenberg MC, Staropoli I, Ermak N, Macraigne L, Morbieu C, Henriquez S, Veyer D, Péré H, Casadevall M, Mouthon L, Rieux-Laucat F, Chatenoud L, Schwartz O, Terrier B. Hadjadj J, et al. Ann Rheum Dis. 2022 May;81(5):720-728. doi: 10.1136/annrheumdis-2021-221508. Epub 2022 Jan 12. Ann Rheum Dis. 2022. PMID: 35022159
• Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.

  Nicolaidou V, Georgiou R, Christofidou M, Felekkis K, Pieri M, Papaneophytou C. Nicolaidou V, et al. Int J Mol Sci. 2023 Feb 3;24(3):2957. doi: 10.3390/ijms24032957. Int J Mol Sci. 2023. PMID: 36769279 Free PMC article.